Serum factors responsible for unusual induction of plasminogen activator activity in tuberous sclerosis.
Peripheral blood lymphocytes derived from tuberous sclerosis (TS) patients showed unusually high levels of plasminogen activator (PA) activity after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Serum obtained from peripheral blood of TS patients also enhanced the PA activity level when normal control lymphocytes were incubated with the serum prior to MNNG treatment. Factors exhibiting the enhancing activity were eluted with a solution of about 0.70 M KCl on dye-ligand chromatography, which were inhibited on incubation with an anti-human interferon (HuIFN)-beta antibody, but not with anti-HuIFN-alpha or anti-HuIFN-gamma antibodies. Unlike in the case of HuIFN-beta, the eluted samples did not possess antiviral or anticellular activity. Thus, it seems likely that serum from TS patients contains factors which are responsible for the unusual PA induction and which have a similar epitope to HuIFN-beta.
Sugita
K
K
Department of Pediatrics, Chiba University School of Medicine, Japan.
Suzuki
N
N
Isogai
E
E
Niimi
H
H
D000293:Adolescent; D000328:Adult; D000906:Antibodies; D000911:Antibodies, Monoclonal; D001790:Blood Physiological Phenomena; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D016899:Interferon-beta / Q000494:pharmacology; D007371:Interferon-gamma / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology*; D010960:Plasminogen Activators / Q000097:blood*; D012016:Reference Values; D014402:Tuberous Sclerosis / Q000097:blood* / Q000201:enzymology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D016898:Interferon-alpha; D008769:Methylnitronitrosoguanidine; D016899:Interferon-beta; D007371:Interferon-gamma; D010960:Plasminogen Activators